MicroRNA-dependent cross-talk between VEGF and HIF1α in the diabetic retina

Shukuan Ling, Yochai Birnbaum, Manjyot K. Nanhwan, Bejoy Thomas, Mandeep Bajaj, Yumei Ye

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Both HIF1α (hypoxia-inducible factor alpha) and VEGF (vascular endothelial growth factor) are implicated in the pathogenesis of diabetic retinopathy (DR). Competitive endogenous RNAs (ceRNAs) are messenger RNA (mRNA) molecules that affect each other expression through competition for their shared microRNAs (miRNA). However, little is known about the role of ceRNAs in DR. We assess whether the expression of HIF1α and VEGF in DR is interdependent through sequestration of common miRNAs. We used bioinformatics to identify potential miRNAs that affect both genes and validated the interdependence of the genes by silencing or overexpression of the genes and assessed the luciferase-HIF1α 3'UTR activity. We found that HIF1α and VEGF are targeted by 12 common miRNAs. Silencing either HIF1α or VEGF increased the availabilities of the shared miRNAs, therefore suppressed the luciferase-HIF1α 3'UTR activity, whereas over-expressing HIF1α or VEGF increased the luciferase activity. HIF1α was co-expressed with VEGF in-vivo and in-vitro in DR models. Silencing HIF1α transcripts resulted in a significant reduction in VEGF protein levels and vice versa. This interdependence was miRNA- and 3'UTR-dependent, as silencing Dicer abolished the interdependence. Over-expression of a common miRNA (miR-106a) significantly reduced the expression of HIF1α and VEGF and prevented high glucose-induced increased permeability. There is a cross-talk between HIF1α and VEGF through interactions with their common miRNAs. miRNA based therapy can affect the expression of both HIF1α and VEGF and may represent a therapeutic potential for the treatment of DR.

Original languageEnglish (US)
Pages (from-to)2840-2847
Number of pages8
JournalCellular Signalling
Volume25
Issue number12
DOIs
StatePublished - 2013

Fingerprint

MicroRNAs
Vascular Endothelial Growth Factor A
Retina
Diabetic Retinopathy
3' Untranslated Regions
Luciferases
RNA
Gene Silencing
Computational Biology
Genes
Permeability
Glucose
Messenger RNA
Therapeutics

Keywords

  • CeRNA
  • Diabetic retinopathy
  • HIF1α
  • MicroRNA
  • VEGF

ASJC Scopus subject areas

  • Cell Biology
  • Medicine(all)

Cite this

MicroRNA-dependent cross-talk between VEGF and HIF1α in the diabetic retina. / Ling, Shukuan; Birnbaum, Yochai; Nanhwan, Manjyot K.; Thomas, Bejoy; Bajaj, Mandeep; Ye, Yumei.

In: Cellular Signalling, Vol. 25, No. 12, 2013, p. 2840-2847.

Research output: Contribution to journalArticle

Ling, S, Birnbaum, Y, Nanhwan, MK, Thomas, B, Bajaj, M & Ye, Y 2013, 'MicroRNA-dependent cross-talk between VEGF and HIF1α in the diabetic retina', Cellular Signalling, vol. 25, no. 12, pp. 2840-2847. https://doi.org/10.1016/j.cellsig.2013.08.039
Ling, Shukuan ; Birnbaum, Yochai ; Nanhwan, Manjyot K. ; Thomas, Bejoy ; Bajaj, Mandeep ; Ye, Yumei. / MicroRNA-dependent cross-talk between VEGF and HIF1α in the diabetic retina. In: Cellular Signalling. 2013 ; Vol. 25, No. 12. pp. 2840-2847.
@article{cadd3341ca48424fa5c416713831ab43,
title = "MicroRNA-dependent cross-talk between VEGF and HIF1α in the diabetic retina",
abstract = "Both HIF1α (hypoxia-inducible factor alpha) and VEGF (vascular endothelial growth factor) are implicated in the pathogenesis of diabetic retinopathy (DR). Competitive endogenous RNAs (ceRNAs) are messenger RNA (mRNA) molecules that affect each other expression through competition for their shared microRNAs (miRNA). However, little is known about the role of ceRNAs in DR. We assess whether the expression of HIF1α and VEGF in DR is interdependent through sequestration of common miRNAs. We used bioinformatics to identify potential miRNAs that affect both genes and validated the interdependence of the genes by silencing or overexpression of the genes and assessed the luciferase-HIF1α 3'UTR activity. We found that HIF1α and VEGF are targeted by 12 common miRNAs. Silencing either HIF1α or VEGF increased the availabilities of the shared miRNAs, therefore suppressed the luciferase-HIF1α 3'UTR activity, whereas over-expressing HIF1α or VEGF increased the luciferase activity. HIF1α was co-expressed with VEGF in-vivo and in-vitro in DR models. Silencing HIF1α transcripts resulted in a significant reduction in VEGF protein levels and vice versa. This interdependence was miRNA- and 3'UTR-dependent, as silencing Dicer abolished the interdependence. Over-expression of a common miRNA (miR-106a) significantly reduced the expression of HIF1α and VEGF and prevented high glucose-induced increased permeability. There is a cross-talk between HIF1α and VEGF through interactions with their common miRNAs. miRNA based therapy can affect the expression of both HIF1α and VEGF and may represent a therapeutic potential for the treatment of DR.",
keywords = "CeRNA, Diabetic retinopathy, HIF1α, MicroRNA, VEGF",
author = "Shukuan Ling and Yochai Birnbaum and Nanhwan, {Manjyot K.} and Bejoy Thomas and Mandeep Bajaj and Yumei Ye",
year = "2013",
doi = "10.1016/j.cellsig.2013.08.039",
language = "English (US)",
volume = "25",
pages = "2840--2847",
journal = "Cellular Signalling",
issn = "0898-6568",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - MicroRNA-dependent cross-talk between VEGF and HIF1α in the diabetic retina

AU - Ling, Shukuan

AU - Birnbaum, Yochai

AU - Nanhwan, Manjyot K.

AU - Thomas, Bejoy

AU - Bajaj, Mandeep

AU - Ye, Yumei

PY - 2013

Y1 - 2013

N2 - Both HIF1α (hypoxia-inducible factor alpha) and VEGF (vascular endothelial growth factor) are implicated in the pathogenesis of diabetic retinopathy (DR). Competitive endogenous RNAs (ceRNAs) are messenger RNA (mRNA) molecules that affect each other expression through competition for their shared microRNAs (miRNA). However, little is known about the role of ceRNAs in DR. We assess whether the expression of HIF1α and VEGF in DR is interdependent through sequestration of common miRNAs. We used bioinformatics to identify potential miRNAs that affect both genes and validated the interdependence of the genes by silencing or overexpression of the genes and assessed the luciferase-HIF1α 3'UTR activity. We found that HIF1α and VEGF are targeted by 12 common miRNAs. Silencing either HIF1α or VEGF increased the availabilities of the shared miRNAs, therefore suppressed the luciferase-HIF1α 3'UTR activity, whereas over-expressing HIF1α or VEGF increased the luciferase activity. HIF1α was co-expressed with VEGF in-vivo and in-vitro in DR models. Silencing HIF1α transcripts resulted in a significant reduction in VEGF protein levels and vice versa. This interdependence was miRNA- and 3'UTR-dependent, as silencing Dicer abolished the interdependence. Over-expression of a common miRNA (miR-106a) significantly reduced the expression of HIF1α and VEGF and prevented high glucose-induced increased permeability. There is a cross-talk between HIF1α and VEGF through interactions with their common miRNAs. miRNA based therapy can affect the expression of both HIF1α and VEGF and may represent a therapeutic potential for the treatment of DR.

AB - Both HIF1α (hypoxia-inducible factor alpha) and VEGF (vascular endothelial growth factor) are implicated in the pathogenesis of diabetic retinopathy (DR). Competitive endogenous RNAs (ceRNAs) are messenger RNA (mRNA) molecules that affect each other expression through competition for their shared microRNAs (miRNA). However, little is known about the role of ceRNAs in DR. We assess whether the expression of HIF1α and VEGF in DR is interdependent through sequestration of common miRNAs. We used bioinformatics to identify potential miRNAs that affect both genes and validated the interdependence of the genes by silencing or overexpression of the genes and assessed the luciferase-HIF1α 3'UTR activity. We found that HIF1α and VEGF are targeted by 12 common miRNAs. Silencing either HIF1α or VEGF increased the availabilities of the shared miRNAs, therefore suppressed the luciferase-HIF1α 3'UTR activity, whereas over-expressing HIF1α or VEGF increased the luciferase activity. HIF1α was co-expressed with VEGF in-vivo and in-vitro in DR models. Silencing HIF1α transcripts resulted in a significant reduction in VEGF protein levels and vice versa. This interdependence was miRNA- and 3'UTR-dependent, as silencing Dicer abolished the interdependence. Over-expression of a common miRNA (miR-106a) significantly reduced the expression of HIF1α and VEGF and prevented high glucose-induced increased permeability. There is a cross-talk between HIF1α and VEGF through interactions with their common miRNAs. miRNA based therapy can affect the expression of both HIF1α and VEGF and may represent a therapeutic potential for the treatment of DR.

KW - CeRNA

KW - Diabetic retinopathy

KW - HIF1α

KW - MicroRNA

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=84884733452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884733452&partnerID=8YFLogxK

U2 - 10.1016/j.cellsig.2013.08.039

DO - 10.1016/j.cellsig.2013.08.039

M3 - Article

C2 - 24018047

AN - SCOPUS:84884733452

VL - 25

SP - 2840

EP - 2847

JO - Cellular Signalling

JF - Cellular Signalling

SN - 0898-6568

IS - 12

ER -